Table 3.

Results of univariate analysis concerning 5-year survival of the LUSC patients

Clinical features	Patients (N = 73)	5-year survival (%)		P
		patients	Rate (%)
Gender				0.711
Male	66	26	39.4
Female	7	3	42.9
Age				0.451
< 60	23	10	43.5
≥ 60	50	19	38.0
Differentiation				0.928
Good	3	2	66.7
Moderate	53	21	39.6
Poor	17	6	35.3
pT classification				0.465
pT1	12	6	50.0
pT2	32	13	40.6
pT3	29	10	34.5
pN				0.001
−	27	19	70.4
+	46	10	21.7
pTNM stage				0.001
pI	12	9	75.0
pII	30	15	50.0
pIIIa	31	5	16.1
YTHDF2 expression				0.002
Low	29	16	55.2
High	44	13	29.5

P-Log-rank test; pT classification, tumor size; pN, lymph node metastasis and pTNM stage, tumor stage